CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial

MLA

Danel, Christine, et al. “CD4-Guided Structured Antiretroviral Treatment Interruption Strategy in HIV-Infected Adults in West Africa (Trivacan ANRS 1269 Trial): A Randomised Trial.” The Lancet, vol. 367, no. 9527, June 2006, p. 1981. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.197110113&authtype=sso&custid=ns315887.

APA

Danel, C., Moh, R., Minga, A., Anzian, A., Ba-Gomis, O., Kanga, C., Nzunetu, G., Gabillard, D., Rouet, F., Sorho, S., Chaix, M.-L., Eholie, S., Menan, H., Sauvageot, D., Bissagnene, E., Salamon, R., & Anglaret, X. (2006). CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial. The Lancet, 367(9527), 1981.

Chicago

Danel, Christine, Raoul Moh, Albert Minga, Amani Anzian, Olivier Ba-Gomis, Constance Kanga, Gustave Nzunetu, et al. 2006. “CD4-Guided Structured Antiretroviral Treatment Interruption Strategy in HIV-Infected Adults in West Africa (Trivacan ANRS 1269 Trial): A Randomised Trial.” The Lancet 367 (9527): 1981. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.197110113&authtype=sso&custid=ns315887.